Title | |
Publication Type | Journal Article |
Year of Publication | 2019 |
Authors | Krishnaswami A, Steinman MA, Goyal P, Zullo AR, Anderson TS, Birtcher KK, Goodlin SJ, Maurer MS, Alexander KP, Rich MW, Tjia J |
Corporate Authors | Geriatric Cardiology Section Leadership Council, American College of Cardiology |
Journal | J Am Coll Cardiol |
Volume | 73 |
Issue | 20 |
Pagination | 2584-2595 |
Date Published | 2019 05 28 |
ISSN | 1558-3597 |
Keywords | Aged, Cardiovascular Diseases, Comorbidity, Deprescriptions, Drug-Related Side Effects and Adverse Reactions, Global Health, Humans, Inappropriate Prescribing, Incidence |
Abstract | Deprescribing, an integral component of a continuum of good prescribing practices, is the process of medication withdrawal or dose reduction to correct or prevent medication-related complications, improve outcomes, and reduce costs. Deprescribing is particularly applicable to the commonly encountered multimorbid older adult with cardiovascular disease and concomitant geriatric conditions such as polypharmacy, frailty, and cognitive dysfunction-a combination rarely addressed in current clinical practice guidelines. Triggers to deprescribe include present or expected adverse drug reactions, unnecessary polypharmacy, and the need to align medications with goals of care when life expectancy is reduced. Using a framework to deprescribe, this review addresses the rationale, evidence, and strategies for deprescribing cardiovascular and some noncardiovascular medications. |
DOI | 10.1016/j.jacc.2019.03.467 |
Alternate Journal | J. Am. Coll. Cardiol. |
PubMed ID | 31118153 |
PubMed Central ID | PMC6724706 |
Grant List | L30 AG060493 / AG / NIA NIH HHS / United States R03 AG056446 / AG / NIA NIH HHS / United States L30 AG060521 / AG / NIA NIH HHS / United States K24 AG036778 / AG / NIA NIH HHS / United States K24 AG049057 / AG / NIA NIH HHS / United States U13 AG047008 / AG / NIA NIH HHS / United States |